Investor

Providers are responsible for navigating variable coverage schemes while caring for patients, says Jay Rughani, investment partner at Andreessen Horowitz. AI and LLMs advancements can help fix this trajectory and reduce administrative burnout.  

The funds come two years after the company scored a $1.15 billion investment.

The company offers diagnostic tests and therapeutics to detect and treat endometriosis, female fertility and bacterial vaginosis.

Jay Rughani, investment partner at a16z, discusses 2023 events, predictions for digital health funding in 2024 and proper AI regulation to avoid stifling innovation.

Thomas Hallisey, HANYS digital health strategy lead, discusses appropriate regulations on digital health at the state and federal levels and the need for continuous management as technology moves from automating healthcare to augmenting it.  

Sehat Kahani is now exploring predictive AI in telehealth.

Also, Cipla has increased its stake in digital pharma solutions company GoApptiv.

AI is a tool to help people everywhere realize their health potential, said HIMSS Chief Scientific Research Officer Anne Snowden. If there was a time for learning, sharing and building a community of AI decision-making tools, it is now.  

The company announced the appointments of numerous individuals to its executive team and will use the funds to expand its partnerships and oncology platform.

As host of HIMSS AI in Healthcare Forum, Robert Havasy, senior director of the Personal Connected Health Alliance at HIMSS, discusses the cautious optimism and warnings he heard from speakers and attendees about AI technology and its progress.